Company Paxman AB

Equities

PAX

SE0009806284

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Paxman AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 09:24:14 2024-04-17 am EDT			5-day change	1st Jan Change
35.7 ^SEK	+0.28%		-0.83%	-2.99%

Jan. 15	Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company's primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.

Number of employees: 91

SEK in Million	2021	Weight	2022	Weight	Delta
Scalp Cooling Technology 100.0 %	96	100.0 %	146	100.0 %	+51.68%

SEK in Million	2021	Weight	2022	Weight	Delta
United States 49.4 %	49	51.3 %	72	49.4 %	+46.03%
United Kingdom 17.2 %	18	18.4 %	25	17.2 %	+41.80%
Rest of Europe 11.3 %	12	12.6 %	17	11.3 %	+35.76%
Asia 9.6 %	7	6.9 %	14	9.6 %	+110.57%
Rest of America 5.9 %	3	3.5 %	9	5.9 %	+157.40%
Netherlands 4.2 %	5	5.3 %	6	4.2 %	+18.54%
Australia 2.5 %	2	1.9 %	4	2.5 %	+95.97%
Africa 0.0 %	0	0.1 %	0	0.0 %	-75.00%

Managers	Title	Age	Since
Richard Paxman CEO	Chief Executive Officer	41	16-12-19
Emelie Gustafsson DFI	Director of Finance/CFO	44	20-02-29
Patrick Burke CTO	Chief Tech/Sci/R&D Officer	65	08-12-31
Liza Hirst HRO	Human Resources Officer	50	93-12-31
Susy Brown SAM	Sales & Marketing	37	17-12-31
Alexandra Sheldrake LAW	General Counsel	39	08-12-31
Claire Paxman SAM	Sales & Marketing	46	09-12-31

Members of the board	Title	Age	Since
Björn Littorin BRD	Director/Board Member	77	16-11-30
Per-Anders Karl Johansson CHM	Chairman	70	16-11-30
Maria Bech BRD	Director/Board Member	56	16-12-19
Richard Paxman CEO	Chief Executive Officer	41	16-12-19
Glenn Paxman FOU	Founder	68	95-12-31
Robert Kelly BRD	Director/Board Member	63	16-12-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	19,012,500	6,899,572 ( 36.29 %)	0	36.29 %

Name	Equities	%	Valuation
Glenn Paxman 30.28 %	5,757,395	30.28 %	20 M kr
Per-Anders Karl Johansson 8.305 %	1,578,992	8.305 %	6 M kr
Richard Paxman 6.738 %	1,281,000	6.738 %	4 M kr
The Bank of New York Mellon Corp. (Investment Management) 5.236 %	995,584	5.236 %	3 M kr
Alcur Fonder AB 4.241 %	806,327	4.241 %	3 M kr
Länsförsäkringar Fondförvaltning AB 3.077 %	585,000	3.077 %	2 M kr
Länsförsäkringar Kalmar län 2.868 %	545,185	2.868 %	2 M kr
Björn Littorin 2.446 %	465,076	2.446 %	2 M kr
Andra AP-fonden 2.402 %	456,617	2.402 %	2 M kr
Robert Kelly 0.5851 %	111,250	0.5851 %	390 165 kr

Paxman AB

Pirgatan 13

374 35, Karlshamn

http://www.paxman.se

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PAXMAN AB	-2.99%	61.86M
MEDTRONIC PLC	-4.01%	105B
BECTON, DICKINSON AND COMPANY	-4.77%	66.74B
DEXCOM, INC.	+7.87%	52.63B
CENCORA, INC.	+16.18%	47.48B
HOYA CORPORATION	+0.31%	39.68B
WEST PHARMACEUTICAL SERVICES, INC.	+7.17%	27.78B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.23%	26.27B
SARTORIUS STEDIM BIOTECH	+3.80%	26.11B
TERUMO CORPORATION	+10.54%	25.38B

Other Medical Equipment, Supplies & Distribution